Ok, so we know that this month, we really should n
Post# of 36537
(Total Views: 288)
Posted On: 12/10/2020 11:06:58 AM
Ok, so we know that this month, we really should not be expecting much to go on.
So, let’s take a new approach here. It’s the end of the year, Generex/NGIO is hanging in there with deals, products, peer reviews. The SEC has approved most S1’s so far and it looks like the listing for NGIO is still a go.
Here’s to looking for a good New Year, expectations of the VA hospitals finally opening back up, Arizona making progress and we see NGIO listed in the first few months of the new year. We see NGIO listed at 5 or 6 PPS with the deals and possibly more news that might come out over the next few months as well.
So, let’s take a new approach here. It’s the end of the year, Generex/NGIO is hanging in there with deals, products, peer reviews. The SEC has approved most S1’s so far and it looks like the listing for NGIO is still a go.
Here’s to looking for a good New Year, expectations of the VA hospitals finally opening back up, Arizona making progress and we see NGIO listed in the first few months of the new year. We see NGIO listed at 5 or 6 PPS with the deals and possibly more news that might come out over the next few months as well.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼